SPI Medical Imaging: New Funding Illuminates the Path for LUMA Vision

Published 01/02/2024

Written by

Phil Grainger headshot
Phil Grainger
Market Intelligence Reports
01 Aug 2023: Market Intelligence Services, Market Reports, Medical Imaging, Modalities, Ultrasound - Market Intelligence Service
Ultrasound Equipment – World – 2023
This is the sixth edition of this report, which is trusted by 9 of the top 10 global ultrasound...
Arrow Right

Share article:

LUMA Vision, developer of a 4D cardiac imaging and navigation platform, has announced a total of $22 million in new financing for the company. The Series A3 financing added three new investors comprising an undisclosed multinational strategic investor, Atlantic Bridge Growth Fund and Bayern Kapital, and was led by existing investors EQT Lifesciences, ABV Uni Fund and imec.xpand.

LUMA Vision intends to use the new funds to gain FDA clearance, prepare for US commercialisation and develop the next generations of its VERAFEYE platform for additional clinical applications in cardiology and beyond.

Combined with grants previously won by LUMA Vision, this investment provides the company with a considerable war chest, however it still might not be enough to contend with the challenges ahead.